Nuclear Medicine and Radiopharmaceutic Market Report

Japan Nuclear Medicine and Radiopharmaceutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Jun 04, 2020
  • PAGES：183
  • REPORT CODE：GMM537047
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Nuclear Medicine and Radiopharmaceutic market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Nuclear Medicine and Radiopharmaceutic market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine and Radiopharmaceutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Company

    • IBA Group

    • SIEMENS

    • Jubilant Pharma

    • Dongcheng

    • Mallinckrodt

    • Bayer

    • Lantheus

    • Eli Lilly

    • Navidea

    • Triad Isotopes

    • Nordion

    • Bracco Imaging

    • GE Healthcare

    • China Isotope & Radiation

    • Advanced Accelerator Applications

    By Type:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology

    • Cardiology

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine and Radiopharmaceutic Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

      • 1.3.2 Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Oncology

      • 1.4.2 Market Size and Growth Rate of Cardiology

      • 1.4.3 Market Size and Growth Rate of Others

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine and Radiopharmaceutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine and Radiopharmaceutic by Major Types

      • 3.4.1 Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

      • 3.4.2 Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    4 Segmentation of Nuclear Medicine and Radiopharmaceutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine and Radiopharmaceutic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceutic in Oncology

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceutic in Cardiology

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceutic in Others

    5 Market Analysis by Regions

    • 5.1 Japan Nuclear Medicine and Radiopharmaceutic Production Analysis by Regions

    • 5.2 Japan Nuclear Medicine and Radiopharmaceutic Consumption Analysis by Regions

    6 Hokkaido Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 6.1 Hokkaido Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 6.2 Hokkaido Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    7 Tohoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 7.1 Tohoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 7.2 Tohoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    8 Kanto Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 8.1 Kanto Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 8.2 Kanto Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    9 Chubu Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 9.1 Chubu Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 9.2 Chubu Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    10 Kinki Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 10.1 Kinki Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 10.2 Kinki Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    11 Chugoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 11.1 Chugoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 11.2 Chugoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    12 Shikoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 12.1 Shikoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 12.2 Shikoku Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    13 Kyushu Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 13.1 Kyushu Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 13.2 Kyushu Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Company

      • 14.1.1 Company Company Profile and Recent Development

      • 14.1.2 Company Market Performance

      • 14.1.3 Company Product and Service Introduction

    • 14.2 IBA Group

      • 14.2.1 IBA Group Company Profile and Recent Development

      • 14.2.2 IBA Group Market Performance

      • 14.2.3 IBA Group Product and Service Introduction

    • 14.3 SIEMENS

      • 14.3.1 SIEMENS Company Profile and Recent Development

      • 14.3.2 SIEMENS Market Performance

      • 14.3.3 SIEMENS Product and Service Introduction

    • 14.4 Jubilant Pharma

      • 14.4.1 Jubilant Pharma Company Profile and Recent Development

      • 14.4.2 Jubilant Pharma Market Performance

      • 14.4.3 Jubilant Pharma Product and Service Introduction

    • 14.5 Dongcheng

      • 14.5.1 Dongcheng Company Profile and Recent Development

      • 14.5.2 Dongcheng Market Performance

      • 14.5.3 Dongcheng Product and Service Introduction

    • 14.6 Mallinckrodt

      • 14.6.1 Mallinckrodt Company Profile and Recent Development

      • 14.6.2 Mallinckrodt Market Performance

      • 14.6.3 Mallinckrodt Product and Service Introduction

    • 14.7 Bayer

      • 14.7.1 Bayer Company Profile and Recent Development

      • 14.7.2 Bayer Market Performance

      • 14.7.3 Bayer Product and Service Introduction

    • 14.8 Lantheus

      • 14.8.1 Lantheus Company Profile and Recent Development

      • 14.8.2 Lantheus Market Performance

      • 14.8.3 Lantheus Product and Service Introduction

    • 14.9 Eli Lilly

      • 14.9.1 Eli Lilly Company Profile and Recent Development

      • 14.9.2 Eli Lilly Market Performance

      • 14.9.3 Eli Lilly Product and Service Introduction

    • 14.10 Navidea

      • 14.10.1 Navidea Company Profile and Recent Development

      • 14.10.2 Navidea Market Performance

      • 14.10.3 Navidea Product and Service Introduction

    • 14.11 Triad Isotopes

      • 14.11.1 Triad Isotopes Company Profile and Recent Development

      • 14.11.2 Triad Isotopes Market Performance

      • 14.11.3 Triad Isotopes Product and Service Introduction

    • 14.12 Nordion

      • 14.12.1 Nordion Company Profile and Recent Development

      • 14.12.2 Nordion Market Performance

      • 14.12.3 Nordion Product and Service Introduction

    • 14.13 Bracco Imaging

      • 14.13.1 Bracco Imaging Company Profile and Recent Development

      • 14.13.2 Bracco Imaging Market Performance

      • 14.13.3 Bracco Imaging Product and Service Introduction

    • 14.14 GE Healthcare

      • 14.14.1 GE Healthcare Company Profile and Recent Development

      • 14.14.2 GE Healthcare Market Performance

      • 14.14.3 GE Healthcare Product and Service Introduction

    • 14.15 China Isotope & Radiation

      • 14.15.1 China Isotope & Radiation Company Profile and Recent Development

      • 14.15.2 China Isotope & Radiation Market Performance

      • 14.15.3 China Isotope & Radiation Product and Service Introduction

    • 14.16 Advanced Accelerator Applications

      • 14.16.1 Advanced Accelerator Applications Company Profile and Recent Development

      • 14.16.2 Advanced Accelerator Applications Market Performance

      • 14.16.3 Advanced Accelerator Applications Product and Service Introduction

     

    The List of Tables and Figures (Totals 84 Figures and 194 Tables)

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Others

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine and Radiopharmaceutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine and Radiopharmaceutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine and Radiopharmaceutic by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceutic by Different Types from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine and Radiopharmaceutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceutic by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Others

    • Table Japan Nuclear Medicine and Radiopharmaceutic Production by Regions

    • Table Japan Nuclear Medicine and Radiopharmaceutic Production Share by Regions

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Production Share by Regions in 2014

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Production Share by Regions in 2018

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Production Share by Regions in 2026

    • Table Japan Nuclear Medicine and Radiopharmaceutic Consumption by Regions

    • Table Japan Nuclear Medicine and Radiopharmaceutic Consumption Share by Regions

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Consumption Share by Regions in 2014

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Consumption Share by Regions in 2018

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Consumption Share by Regions in 2026

    • Table Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Hokkaido Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Tohoku Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Tohoku Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Tohoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Kanto Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Kanto Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Kanto Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Chubu Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Chubu Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Chubu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Kinki Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Kinki Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Kinki Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Chugoku Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Chugoku Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Chugoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Shikoku Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Shikoku Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Shikoku Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Kyushu Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2014

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2018

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by Types in 2026

    • Table Kyushu Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2014

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2018

    • Figure Kyushu Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company

    • Figure Sales and Growth Rate Analysis of Company

    • Figure Revenue and Market Share Analysis of Company

    • Table Product and Service Introduction of Company

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US